4-[2-(3,4-dichlorophenyl)-ethyl]-benzenamine | 104800-02-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: 4-[2-(3,4-dichlorophenyl)-ethyl]-benzenamine
• 英文别名: 4-(2-(3,4-dichlorophenyl)ethyl)aniline；4-[2-(3,4-Dichlorophenyl)ethyl]benzenamine；4-(3,4-Dichlorophenethyl)aniline；4-[2-(3,4-dichlorophenyl)ethyl]aniline
• CAS: 104800-02-4
• 化学式: C₁₄H₁₃Cl₂N
• 分子量: 266.17
• InChiKey: DJRMLOWAILQPBR-UHFFFAOYSA-N

物化性质

• 沸点：
  377.9±32.0 °C(Predicted)
• 密度：
  1.272±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-[2-(3,4-dichlorophenyl)-ethyl]-benzenamine 以52%的产率得到
  参考文献：
  名称：

  CARETHERS, MARY E.;CETENKO, WIACZESLAW A.;CONNOR, DAVID T.;JOHNSON, ELIZA+

  摘要：

  DOI：
• 作为产物：
  描述：

  1,2-dichloro-4-[2-(4-nitrophenyl)ethenyl]benzene 在 aluminum nickel 氢气 作用下， 以 四氢呋喃 为溶剂， 以26.6 g (86%)的产率得到4-[2-(3,4-dichlorophenyl)-ethyl]-benzenamine
  参考文献：
  名称：

  Diphenic acid monoamides

  摘要：

  本发明提供了各种新型二苯甲酸单酰胺化合物、新型药物组合物以及其使用的方法，以及新型的合成方法。本发明的新型二苯甲酸单酰胺是白三烯拮抗剂、5-脂氧合酶抑制剂和介质释放抑制剂，具有用于治疗哮喘、过敏、心血管疾病、偏头痛和免疫炎症症状的活性。

  公开号：

  US04602023A1

文献信息

• The synthesis and structure–activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors
  作者：Lloyd J. Simons、Bradley W. Caprathe、Michael Callahan、James M. Graham、Takenori Kimura、Yingjie Lai、Harry LeVine、William Lipinski、Annette T. Sakkab、Yoshikazu Tasaki、Lary C. Walker、Tomoyuki Yasunaga、Yuyang Ye、Nian Zhuang、Corinne E. Augelli-Szafran

  DOI：10.1016/j.bmcl.2008.12.049

  日期：2009.2

  Alzheimer’s disease. In the course of our studies to identify β-amyloid aggregation inhibitors, a series of N-phenyl anthranilic acid analogs were synthesized and studied for β-amyloid inhibition activity. The synthesis, structure–activity relationship, and in vivo activity of these analogs are discussed.

  认为β-淀粉样蛋白聚集是阿尔茨海默氏病发展中的重要事件。在我们鉴定β-淀粉样蛋白聚集抑制剂的研究过程中，合成了一系列N-苯基邻氨基苯甲酸类似物，并研究了β-淀粉样蛋白抑制活性。讨论了这些类似物的合成，结构-活性关系以及体内活性。
• METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY NUCLEOPHILIC AROMATIC SUBSTITUTION OF AROMATIC CARBOXYLIC ACID DERIVATIVES SUPPORTING AT LEAST ONE ELECTRO-ATTRACTIVE GROUP
  申请人：Mortier Jacques

  公开号：US20120316337A1

  公开（公告）日：2012-12-13

  Method for preparing carboxylic acid derivatives by aromatic nucleophilic substitution, in which a carboxylic acid derivative having a single carboxyl functional group, or one of the salts thereof, the carboxylic acid derivative having, in the ortho position of the carboxyl functional group, a leaving group, which is preferably an atom of fluorine or of chlorine or an alkoxy group, chiral or not, preferably a methoxy group, the carboxylic acid derivative not being substituted by an electro attractive group other than the leaving group if any; is reacted with a reactant MNu, where M is a metal and Nu is a nucleophile, chiral or not, the aromatic nucleophilic substitution reaction being carried out without a catalyst and without a step of protecting/deprotecting the acid functional group of the starting compound.

  通过芳香亲核取代法制备羧酸衍生物的方法，其中羧酸衍生物具有单个羧基官能团，或其盐之一，该羧酸衍生物在羧基官能团的邻位具有一个离去基团，该离去基团优选为氟原子或氯原子或烷氧基，手性或非手性，优选为甲氧基，如果有的话，该羧酸衍生物未被电子亲合基团取代；与反应物MNu发生反应，其中M为金属，Nu为亲核试剂，手性或非手性，芳香亲核取代反应在无催化剂和无保护/去保护起始化合物的酸官能团的步骤的情况下进行。
• Enolamides, pharmaceutical compositions and methods for treating
  申请人：Warner-Lambert Company

  公开号：US04761424A1

  公开（公告）日：1988-08-02

  The present invention relates to novel enolamide type compounds, pharmaceutical compositions, and methods of use thereof, useful in the treatment of diseases in which products of lipoxygenase enzyme activity or the action of leukotrienes contribute to the pathological condition.

  本发明涉及新型烯酰胺类化合物、药物组合物及其使用方法，适用于治疗疾病，其中脂氧酶酶活性产物或白三烯的作用促成了病理状况。
• N-substituted-2-hydroxy-.alpha.-oxo-benzeneacetamides and pharmaceutical
  申请人：Warner-Lambert Company

  公开号：US04939133A1

  公开（公告）日：1990-07-03

  The present invention relates to novel N-substituted 2-hydroxybenzamide and N-substituted 2-hydroxy-.alpha.-oxo-benezene acetamide compounds pharmaceutical compositions, and methods of use for therefore for the treatment of diseases in which products having lipoxygenase enzyme activity contribute to the pathological condition. Selected novel intermediates are also the present invention.

  本发明涉及新型N-取代的2-羟基苯甲酰胺和N-取代的2-羟基-α-氧代苯乙酰胺化合物药物组合物，以及用于治疗病变中脂氧合酶酶活性产物导致病理状况的方法。所述发明还涉及选定的新型中间体。
• Process for making n-aryl-anthranilic acids and their derivatives
  申请人：——

  公开号：US20040039208A1

  公开（公告）日：2004-02-26

  The present invention relates to a process for the preparation of N-arylanthranilic acids, and a process for the preparation of N-aryl anthranilic esters, amides, and hydroxamic esters.

  本发明涉及一种制备N-芳基蒽酰胺酸的方法，以及制备N-芳基蒽酰酯、酰胺和羟肟酯的方法。